Cerus Corporation (CERS): Price and Financial Metrics
Cerus Corporation (CERS)
Today's Latest Price: $6.58 USD
Updated Nov 27 1:00pm
Add CERS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CERS Stock Summary
- CERS's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 197.27 -- higher than 84.67% of US-listed equities with positive expected earnings growth.
- CERS's price/sales ratio is 10.26; that's higher than the P/S ratio of 85.51% of US stocks.
- As for revenue growth, note that CERS's revenue has grown 22.42% over the past 12 months; that beats the revenue growth of 80.81% of US companies in our set.
- Stocks that are quantitatively similar to CERS, based on their financial statements, market capitalization, and price volatility, are EPZM, MRAM, JG, PSNL, and KIN.
- Visit CERS's SEC page to see the company's official filings. To visit the company's web site, go to www.cerus.com.
CERS Stock Price Chart Interactive Chart >
CERS Price/Volume Stats
| Current price | $6.58 | 52-week high | $7.94 |
| Prev. close | $6.02 | 52-week low | $2.71 |
| Day low | $6.12 | Volume | 1,302,900 |
| Day high | $6.58 | Avg. volume | 1,777,946 |
| 50-day MA | $6.13 | Dividend yield | N/A |
| 200-day MA | $5.91 | Market Cap | 1.10B |
Cerus Corporation (CERS) Company Bio
Cerus Corporation operates as a biomedical products company which focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company was founded in 1991 and is based in Concord, California.
Loading social stream, please wait...